Noureddin M, Jones C, Alkhouri N, Gomez EV, et al. Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis. Gastroenterology 2020;159:1985-1987.
PMID: 32763241